From February 5, 2024 to March 31, 2024, the company has repurchased 10,018,000 shares, representing 2.09% for CNY 148.61 million. With this, the company has completed the repurchase of 10,018,000 shares, representing 2.09% for CNY 148.61 million under the buyback announced on February 6, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.12 CNY | -1.43% | -2.51% | -12.30% |
05-23 | Foyou Pharmaceutical Gets Nod to Market Valproic Acid | MT |
04-23 | Beijing Foyou Pharma CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-12.30% | 981M | |
+38.69% | 728B | |
+34.28% | 603B | |
-4.49% | 360B | |
+20.24% | 332B | |
+2.12% | 279B | |
+17.02% | 244B | |
+9.31% | 207B | |
-5.07% | 205B | |
-0.35% | 163B |
- Stock Market
- Equities
- 601089 Stock
- News Beijing Foyou Pharma CO.,LTD
- Tranche Update on Beijing Foyou Pharma CO.,LTD's Equity Buyback Plan announced on February 6, 2024.